##gff-version 3
##sequence-region Q8IUE6 1 130
Q8IUE6	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823041;Dbxref=PMID:15823041	
Q8IUE6	UniProtKB	Chain	2	130	.	.	.	ID=PRO_0000227505;Note=Histone H2A type 2-B	
Q8IUE6	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823041;Dbxref=PMID:15823041	
Q8IUE6	UniProtKB	Modified residue	2	2	.	.	.	Note=Phosphoserine%3B by RPS6KA5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15010469;Dbxref=PMID:15010469	
Q8IUE6	UniProtKB	Modified residue	4	4	.	.	.	Note=Citrulline%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823041;Dbxref=PMID:15823041	
Q8IUE6	UniProtKB	Modified residue	4	4	.	.	.	Note=Symmetric dimethylarginine%3B by PRMT5%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q64522	
Q8IUE6	UniProtKB	Modified residue	6	6	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	10	10	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	10	10	.	.	.	Note=N6-(beta-hydroxybutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27105115;Dbxref=PMID:27105115	
Q8IUE6	UniProtKB	Modified residue	10	10	.	.	.	Note=N6-succinyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22389435;Dbxref=PMID:22389435	
Q8IUE6	UniProtKB	Modified residue	14	14	.	.	.	Note=N6-(beta-hydroxybutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27105115;Dbxref=PMID:27105115	
Q8IUE6	UniProtKB	Modified residue	37	37	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	37	37	.	.	.	Note=N6-(beta-hydroxybutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27105115;Dbxref=PMID:27105115	
Q8IUE6	UniProtKB	Modified residue	37	37	.	.	.	Note=N6-crotonyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21925322;Dbxref=PMID:21925322	
Q8IUE6	UniProtKB	Modified residue	75	75	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	76	76	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	96	96	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	96	96	.	.	.	Note=N6-(beta-hydroxybutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27105115;Dbxref=PMID:27105115	
Q8IUE6	UniProtKB	Modified residue	96	96	.	.	.	Note=N6-succinyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22389435;Dbxref=PMID:22389435	
Q8IUE6	UniProtKB	Modified residue	105	105	.	.	.	Note=N5-methylglutamine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352239;Dbxref=PMID:24352239	
Q8IUE6	UniProtKB	Modified residue	119	119	.	.	.	Note=N6-(2-hydroxyisobutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681537;Dbxref=PMID:24681537	
Q8IUE6	UniProtKB	Modified residue	119	119	.	.	.	Note=N6-(beta-hydroxybutyryl)lysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27105115;Dbxref=PMID:27105115	
Q8IUE6	UniProtKB	Modified residue	119	119	.	.	.	Note=N6-crotonyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21925322;Dbxref=PMID:21925322	
Q8IUE6	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-crotonyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21925322;Dbxref=PMID:21925322	
Q8IUE6	UniProtKB	Modified residue	121	121	.	.	.	Note=Phosphothreonine%3B by DCAF1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15078818,ECO:0000269|PubMed:24140421;Dbxref=PMID:15078818,PMID:24140421	
Q8IUE6	UniProtKB	Cross-link	14	14	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22713238,ECO:0000269|PubMed:22980979;Dbxref=PMID:22713238,PMID:22980979	
Q8IUE6	UniProtKB	Cross-link	16	16	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22713238,ECO:0000269|PubMed:22980979;Dbxref=PMID:22713238,PMID:22980979	
Q8IUE6	UniProtKB	Cross-link	120	120	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15386022,ECO:0000269|PubMed:16359901,ECO:0000269|PubMed:16702407,ECO:0000269|PubMed:25470042;Dbxref=PMID:15386022,PMID:16359901,PMID:16702407,PMID:25470042	
Q8IUE6	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_035802;Note=In a breast cancer sample%3B somatic mutation. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q8IUE6	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Blocks the inhibition of transcription by RPS6KA5/MSK1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15010469;Dbxref=PMID:15010469	
